
### [NCIT:C4017](http://purl.obolibrary.org/obo/NCIT_C4017)
**Label:** Ductal Breast Carcinoma

**Subclasses:** [NCIT:C76326](http://purl.obolibrary.org/obo/NCIT_C76326) (Metastatic Ductal Breast Carcinoma), [NCIT:C7645](http://purl.obolibrary.org/obo/NCIT_C7645) (Intracystic Papillary Breast Carcinoma), [NCIT:C5137](http://purl.obolibrary.org/obo/NCIT_C5137) (Intraductal Non-Comedo Breast Adenocarcinoma), [NCIT:C5457](http://purl.obolibrary.org/obo/NCIT_C5457) (Invasive Apocrine Breast Carcinoma), [NCIT:C5138](http://purl.obolibrary.org/obo/NCIT_C5138) (Intraductal Cribriform Breast Adenocarcinoma), [NCIT:C9119](http://purl.obolibrary.org/obo/NCIT_C9119) (Medullary Breast Carcinoma), [NCIT:C4189](http://purl.obolibrary.org/obo/NCIT_C4189) (Secretory Breast Carcinoma), [NCIT:C66719](http://purl.obolibrary.org/obo/NCIT_C66719) (Atypical Medullary Breast Carcinoma), [NCIT:C9134](http://purl.obolibrary.org/obo/NCIT_C9134) (Papillary Breast Carcinoma), [NCIT:C7362](http://purl.obolibrary.org/obo/NCIT_C7362) (Scirrhous Breast Carcinoma), [NCIT:C9135](http://purl.obolibrary.org/obo/NCIT_C9135) (Tubular Breast Carcinoma), [NCIT:C5140](http://purl.obolibrary.org/obo/NCIT_C5140) (Apocrine Breast Carcinoma In Situ), [NCIT:C4194](http://purl.obolibrary.org/obo/NCIT_C4194) (Invasive Ductal Carcinoma, Not Otherwise Specified), [NCIT:C66933](http://purl.obolibrary.org/obo/NCIT_C66933) (Ductal Breast Carcinoma In Situ, Solid Type), [NCIT:C5141](http://purl.obolibrary.org/obo/NCIT_C5141) (Apocrine Breast Carcinoma), [NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma), [NCIT:C4190](http://purl.obolibrary.org/obo/NCIT_C4190) (Intraductal Papillary Breast Carcinoma), [NCIT:C9131](http://purl.obolibrary.org/obo/NCIT_C9131) (Mucinous Breast Carcinoma), [NCIT:C36085](http://purl.obolibrary.org/obo/NCIT_C36085) (Invasive Papillary Breast Carcinoma), [NCIT:C40350](http://purl.obolibrary.org/obo/NCIT_C40350) (Breast Carcinoma with Choriocarcinomatous Features), [NCIT:C2924](http://purl.obolibrary.org/obo/NCIT_C2924) (Ductal Breast Carcinoma In Situ), 

**Class expressions from DL-Learner:**

- [NCIT:C36654](http://purl.obolibrary.org/obo/NCIT_C36654) (CDH1 Gene Inactivation) 53.57%
- [NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification) 53.57%
- [NCIT:C36644](http://purl.obolibrary.org/obo/NCIT_C36644) (Loss of E-cadherin Expression) 53.57%
- [NCIT:C36642](http://purl.obolibrary.org/obo/NCIT_C36642) (Cyclin D1 Messenger RNA Overexpression) 53.57%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 53.57%
- [NCIT:C36638](http://purl.obolibrary.org/obo/NCIT_C36638) (ERBB2 Gene Amplification) 53.57%
- [NCIT:C36485](http://purl.obolibrary.org/obo/NCIT_C36485) (CCND1 Protein Overexpression) 53.57%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 53.57%
- [NCIT:C18021](http://purl.obolibrary.org/obo/NCIT_C18021) (CCND1 Gene) 53.57%
- Thing 52.43%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 40.24%
- [NCIT:C25840](http://purl.obolibrary.org/obo/NCIT_C25840) (Cyclin Gene) 38.93%
- [NCIT:C25840](http://purl.obolibrary.org/obo/NCIT_C25840) (Cyclin Gene) and (not ([NCIT:C37051](http://purl.obolibrary.org/obo/NCIT_C37051) (Dysplastic Granulocyte))) 38.93%
- [NCIT:C25840](http://purl.obolibrary.org/obo/NCIT_C25840) (Cyclin Gene) and (not ([NCIT:C3705](http://purl.obolibrary.org/obo/NCIT_C3705) (Pleomorphic Liposarcoma))) 38.93%
- [NCIT:C25840](http://purl.obolibrary.org/obo/NCIT_C25840) (Cyclin Gene) and (not ([NCIT:C37049](http://purl.obolibrary.org/obo/NCIT_C37049) (Hyperchromatic Megakaryocyte))) 38.93%


